🔗 Share this article

Chancellor Reeves has stated she is planning "specific measures to tackle cost of living issues" in the upcoming Budget.

In comments to the BBC, she emphasized that reducing inflation is a collective duty of both the administration and the Bank of England.

The United Kingdom's inflation rate is projected to be the most elevated among the Group of Seven developed nations this calendar year and next.

Possible Energy Bill Interventions

Reports indicate the administration could intervene to bring down utility costs, for example by reducing the present 5% level of VAT applied on energy.

An additional approach is to cut some of the policy costs presently included in household expenses.

Budgetary Constraints and Analyst Expectations

The administration will receive the latest assessment from the independent fiscal watchdog, the Office for Budget Responsibility, on the start of the week, which will reveal how much scope there is for such actions.

The consensus from most experts is that the Chancellor will have to introduce tax increases or spending cuts in order to meet her voluntary debt limits.

Earlier on the same day, analysis showed there was a £22bn shortfall for the Treasury chief to address, which is at the lower end of expectations.

"There's a joint responsibility between the Bank of England and the government to further reduce some of the causes of inflation," the Chancellor stated to the BBC in Washington, at the conferences of the International Monetary Fund and World Bank.

Tax Commitments and International Concerns

While a great deal of the focus has been on probable tax rises, the Treasury chief said the latest figures from the OBR had not changed her vow to campaign commitments not to raise tax levels on earnings tax, sales tax or National Insurance.

She blamed an "uncertain global environment" with increasing geopolitical and commercial concerns for the Budget revenue measures, probably to be focused on those "wealthiest."

International Trade Disputes

Commenting on apprehensions about the United Kingdom's trade ties with China she said: "The UK's national security always are paramount."

Last week's announcement by Chinese authorities to strengthen export controls on critical minerals and other materials that are essential for advanced tech production led US President the US President to suggest an extra 100% tariff on goods from the Asian country, raising the prospect of an all-out commercial conflict between the two global powers.

The US Treasury Secretary described China's decision "economic coercion" and "a global supply chain control attempt."

Inquired about accepting the US offer to join its conflict with China, Reeves said she was "very concerned" by Chinese measures and urged the Chinese government "not to put up barriers and restrict access."

She said the move was "damaging for the global economy and creates additional obstacles."

"I believe there are sectors where we should address Chinese policies, but there are also important opportunities to export to China's economy, including banking sector and other sectors of the economic system. We've got to achieve that equilibrium appropriate."

The Treasury chief also confirmed she was working with G7 counterparts "on our own critical minerals plan, so that we are more independent."

NHS Drug Costs and Investment

The Chancellor also admitted that the cost the NHS spends on pharmaceuticals could go up as a consequence of ongoing negotiations with the Trump administration and its pharmaceutical firms, in return for lower tariffs and capital.

A number of the biggest global drug companies have said lately that they are either halting or abandoning investments in the UK, with several attributing the insufficient payments they are getting.

Last month, the Science Minister said the price the health service pays for drugs would have to increase to prevent businesses and drug research funding departing from the United Kingdom.

The Chancellor told the BBC: "We have seen because of the pricing regime, that drug testing, recent pharmaceuticals have not been available in the United Kingdom in the manner that they are in other EU nations."

"We want to guarantee that people receiving care from the NHS are able to obtain the top life-saving medicines in the world. And so we are reviewing all of that, and... seeking to obtain more funding into Britain."